An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion
Abstract Osteoporosis (OP) is a common age-related disease characterized by a deterioration of bone mass and structure that predisposes patients to fragility fractures. Pharmaceutical therapies that promote anabolic bone formation in OP patients and OP-induced fracture are needed. We investigated wh...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8554920a26d4080a2d68a5e92d3aeba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a8554920a26d4080a2d68a5e92d3aeba |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a8554920a26d4080a2d68a5e92d3aeba2021-11-07T12:09:11ZAn antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion10.1038/s41413-021-00161-12095-6231https://doaj.org/article/a8554920a26d4080a2d68a5e92d3aeba2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41413-021-00161-1https://doaj.org/toc/2095-6231Abstract Osteoporosis (OP) is a common age-related disease characterized by a deterioration of bone mass and structure that predisposes patients to fragility fractures. Pharmaceutical therapies that promote anabolic bone formation in OP patients and OP-induced fracture are needed. We investigated whether a neutralizing antibody against Siglec-15 can simultaneously inhibit bone resorption and stimulate bone formation. We found that the multinucleation of osteoclasts was inhibited in SIGLEC-15 conditional knockout mice and mice undergoing Siglec-15 neutralizing antibody treatment. The secretion of platelet-derived growth factor-BB (PDGF-BB), the number of tartrate-resistant acid phosphatase-positive (TRAP+) mononuclear cells, and bone formation were significantly increased in the SIGLEC-15 conditional knockout mice and antibody-treated mice. The anabolic effect of the Siglec-15 neutralizing antibody on bone formation was blunted in mice with Pdgfb deleted in TRAP+ cells. These findings showed that the anabolic effect of the Siglec-15 neutralizing antibody was mediated by elevating PDGF-BB production of TRAP+ mononuclear cells. To test the therapeutic potential of the Siglec-15 neutralizing antibody, we injected the antibody in an ovariectomy-induced osteoporotic mouse model, which mimics postmenopausal osteoporosis in women, and in two fracture healing models because fracture is the most serious health consequence of osteoporosis. The Siglec-15 neutralizing antibody effectively reduced bone resorption and stimulated bone formation in estrogen deficiency-induced osteoporosis. Of note, the Siglec-15 neutralizing antibody promoted intramembranous and endochondral ossification at the damaged area of cortical bone in fracture healing mouse models. Thus, the Siglec-15 neutralizing antibody shows significant translational potential as a novel therapy for OP and bone fracture.Gehua ZhenYang DanRuomei WangCe DouQiaoyue GuoMelissa ZarrLinda N. LiuLieping ChenRuoxian DengYusheng LiZengwu ShaoXu CaoNature Publishing GrouparticleBiology (General)QH301-705.5PhysiologyQP1-981ENBone Research, Vol 9, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Biology (General) QH301-705.5 Physiology QP1-981 |
spellingShingle |
Biology (General) QH301-705.5 Physiology QP1-981 Gehua Zhen Yang Dan Ruomei Wang Ce Dou Qiaoyue Guo Melissa Zarr Linda N. Liu Lieping Chen Ruoxian Deng Yusheng Li Zengwu Shao Xu Cao An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion |
description |
Abstract Osteoporosis (OP) is a common age-related disease characterized by a deterioration of bone mass and structure that predisposes patients to fragility fractures. Pharmaceutical therapies that promote anabolic bone formation in OP patients and OP-induced fracture are needed. We investigated whether a neutralizing antibody against Siglec-15 can simultaneously inhibit bone resorption and stimulate bone formation. We found that the multinucleation of osteoclasts was inhibited in SIGLEC-15 conditional knockout mice and mice undergoing Siglec-15 neutralizing antibody treatment. The secretion of platelet-derived growth factor-BB (PDGF-BB), the number of tartrate-resistant acid phosphatase-positive (TRAP+) mononuclear cells, and bone formation were significantly increased in the SIGLEC-15 conditional knockout mice and antibody-treated mice. The anabolic effect of the Siglec-15 neutralizing antibody on bone formation was blunted in mice with Pdgfb deleted in TRAP+ cells. These findings showed that the anabolic effect of the Siglec-15 neutralizing antibody was mediated by elevating PDGF-BB production of TRAP+ mononuclear cells. To test the therapeutic potential of the Siglec-15 neutralizing antibody, we injected the antibody in an ovariectomy-induced osteoporotic mouse model, which mimics postmenopausal osteoporosis in women, and in two fracture healing models because fracture is the most serious health consequence of osteoporosis. The Siglec-15 neutralizing antibody effectively reduced bone resorption and stimulated bone formation in estrogen deficiency-induced osteoporosis. Of note, the Siglec-15 neutralizing antibody promoted intramembranous and endochondral ossification at the damaged area of cortical bone in fracture healing mouse models. Thus, the Siglec-15 neutralizing antibody shows significant translational potential as a novel therapy for OP and bone fracture. |
format |
article |
author |
Gehua Zhen Yang Dan Ruomei Wang Ce Dou Qiaoyue Guo Melissa Zarr Linda N. Liu Lieping Chen Ruoxian Deng Yusheng Li Zengwu Shao Xu Cao |
author_facet |
Gehua Zhen Yang Dan Ruomei Wang Ce Dou Qiaoyue Guo Melissa Zarr Linda N. Liu Lieping Chen Ruoxian Deng Yusheng Li Zengwu Shao Xu Cao |
author_sort |
Gehua Zhen |
title |
An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion |
title_short |
An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion |
title_full |
An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion |
title_fullStr |
An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion |
title_full_unstemmed |
An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+ mononuclear cells and PDGF-BB secretion |
title_sort |
antibody against siglec-15 promotes bone formation and fracture healing by increasing trap+ mononuclear cells and pdgf-bb secretion |
publisher |
Nature Publishing Group |
publishDate |
2021 |
url |
https://doaj.org/article/a8554920a26d4080a2d68a5e92d3aeba |
work_keys_str_mv |
AT gehuazhen anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT yangdan anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT ruomeiwang anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT cedou anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT qiaoyueguo anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT melissazarr anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT lindanliu anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT liepingchen anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT ruoxiandeng anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT yushengli anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT zengwushao anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT xucao anantibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT gehuazhen antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT yangdan antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT ruomeiwang antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT cedou antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT qiaoyueguo antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT melissazarr antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT lindanliu antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT liepingchen antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT ruoxiandeng antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT yushengli antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT zengwushao antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion AT xucao antibodyagainstsiglec15promotesboneformationandfracturehealingbyincreasingtrapmononuclearcellsandpdgfbbsecretion |
_version_ |
1718443507559956480 |